Linear IgA bullous dermatosis (LABD) is an autoimmune/inflammatory skin condition. Here, we report on a patient who developed treatment resistant LABD. At diagnosis, elevations of IL-6 and C-reactive protein in the blood and extreme elevations in LABD bullous fluid were seen. The patient responded well to tocilizumab (anti-IL-6 receptor) treatment.